Cotinga Pharmaceuticals ROIC
Was ist das ROIC von Cotinga Pharmaceuticals?
ROIC von Cotinga Pharmaceuticals, Inc. ist -183.57%
Was ist die Definition von ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC von Unternehmen in Health Care Sektor auf TSXV im Vergleich zu Cotinga Pharmaceuticals
Was macht Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Unternehmen mit roic ähnlich Cotinga Pharmaceuticals
- Winc hat ROIC von -185.73%
- Appili Therapeutics Inc hat ROIC von -185.42%
- 22nd Century Inc hat ROIC von -184.82%
- Reviva Pharmaceuticals hat ROIC von -184.14%
- Graycliff Exploration hat ROIC von -184.13%
- Smart Cannabis hat ROIC von -183.89%
- Cotinga Pharmaceuticals hat ROIC von -183.57%
- Comprehensive Healthcare Systems hat ROIC von -183.21%
- Agritek hat ROIC von -182.52%
- Neovasc hat ROIC von -182.46%
- Biolife Sciences Inc hat ROIC von -182.26%
- Galectin Therapeutics Inc hat ROIC von -181.99%
- Wize Pharma hat ROIC von -181.64%